Neumora Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NMRA Nasdaq 2836 www.neumoratx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neumora Therapeutics, Inc.

How Eli Lilly's Plan To Buy Ventyx For $1.2 Billion Could Benefit Neumora, Neurocrine - Jan 8th, 2026 2:10 pm
3 Penny Stocks With Market Caps Under $700M - Jan 8th, 2026 5:05 am
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones - Jan 5th, 2026 4:35 am
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation - Jan 5th, 2026 4:30 am
RBC Sees Upside Potential in Neumora Therapeutics (NMRA) - Jan 3rd, 2026 4:19 am
Promising Penny Stocks To Watch In December 2025 - Dec 2nd, 2025 5:05 am
MapLight Therapeutics, Gold Royalty, and More Stocks See Action From Activist Investors - Nov 7th, 2025 5:26 pm
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 6th, 2025 5:00 am
Neumora Therapeutics to Participate in Upcoming Conferences in November - Nov 3rd, 2025 5:00 am
Neumora Therapeutics (NMRA): Evaluating Valuation Following Dual Pipeline Advances in Psychiatry and Obesity - Oct 31st, 2025 12:12 am
Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating - Oct 30th, 2025 9:29 pm
October 2025's Top Penny Stocks To Watch - Oct 27th, 2025 6:10 am
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898 - Oct 27th, 2025 5:00 am
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model - Oct 27th, 2025 4:30 am
Neumora Therapeutics to Host Virtual R&D Day on October 27 - Oct 1st, 2025 5:00 am
3 Promising Penny Stocks With Market Caps At Least $100M - Sep 22nd, 2025 6:05 am
Apple initiated, Hershey upgraded: Wall Street’s top analyst calls - Sep 17th, 2025 7:40 am
Neumora Therapeutics to Participate in Upcoming Conferences in September - Sep 2nd, 2025 5:00 am
Neumora Therapeutics Initiates Phase 1 Study for Schizophrenia Drug NMRA-861 - Aug 19th, 2025 10:13 pm